These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26491887)

  • 1. Quantitative Proteomics Reveals That the Inhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells.
    Xu Z; Wang F; Fan F; Gu Y; Shan N; Meng X; Cheng S; Liu Y; Wang C; Song Y; Xu R
    J Proteome Res; 2015 Nov; 14(11):4594-602. PubMed ID: 26491887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
    Jin X; Wang J; Zou S; Xu R; Cao J; Zhang Y; Guo J; Wen X; Deng S; Zheng Y; Zhu Y; Wang F; Xu Z
    Am J Chin Med; 2020; 48(3):651-678. PubMed ID: 32349518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting.
    Xu ZW; Wang FM; Gao MJ; Chen XY; Hu WL; Xu RC
    Biol Pharm Bull; 2010; 33(5):743-51. PubMed ID: 20460749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].
    Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
    Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
    Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L
    Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanism study of ouabain in inhibiting the growth of hepatocellular carcinoma cells by inhibiting the laser kinase signaling pathway].
    Fu LN; Xu ZW; Xu RC; Fang T; Wang FM
    Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):3014-3017. PubMed ID: 33086454
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in ouabain-sensitive K+-ATPase activity in hepatocellular carcinoma by overexpression of Na+, K+-ATPase alpha 3-isoform.
    Shibuya K; Fukuoka J; Fujii T; Shimoda E; Shimizu T; Sakai H; Tsukada K
    Eur J Pharmacol; 2010 Jul; 638(1-3):42-6. PubMed ID: 20447393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
    Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
    Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
    Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth.
    Xu ZW; Wang FM; Gao MJ; Chen XY; Shan NN; Cheng SX; Mai X; Zala GH; Hu WL; Xu RC
    J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):181-91. PubMed ID: 21215801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach.
    Zhao LJ; Zhao HY; Wei XL; Guo FF; Wei JY; Wang HJ; Yang J; Yang ZG; Si N; Bian BL
    J Ethnopharmacol; 2020 Oct; 260():112943. PubMed ID: 32422359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
    Chen C; Song G; Xiang J; Zhang H; Zhao S; Zhan Y
    Biochem Biophys Res Commun; 2017 Apr; 486(2):514-520. PubMed ID: 28322787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticancer effects of cinobufagin on hepatocellular carcinoma Huh‑7 cells are associated with activation of the p73 signaling pathway.
    Zhao L; Fu L; Xu Z; Fan R; Xu R; Fu R; Zou S; Wang C; Zhang Y; Wang J; Bao J; Wang Z; Hou X; Zheng Y; Dai E; Wang F
    Mol Med Rep; 2019 May; 19(5):4119-4128. PubMed ID: 30942456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
    Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells.
    Zhu Q; Yu X; Zhou ZW; Zhou C; Chen XW; Zhou SF
    Curr Cancer Drug Targets; 2017; 17(4):386-401. PubMed ID: 27396604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.
    Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y
    Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.